NYSE:HLI - Houlihan Lokey Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $98.40
  • Forecasted Upside: 17.44 %
  • Number of Analysts: 7
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$83.79
▲ +0.13 (0.16%)

This chart shows the closing price for HLI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Houlihan Lokey Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HLI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HLI

Analyst Price Target is $98.40
▲ +17.44% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Houlihan Lokey in the last 3 months. The average price target is $98.40, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 17.44% upside from the last price of $83.79.

This chart shows the closing price for HLI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 7 contributing investment analysts is to hold stock in Houlihan Lokey. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 2 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 2 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 2 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 2 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
11/27/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings
2/25/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 2 sell ratings
4/26/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 2 sell ratings
5/26/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/23/2022The Goldman Sachs GroupLower Price TargetBuy$106.00 ➝ $95.00Low
4/12/2022The Goldman Sachs GroupLower Price TargetBuy$127.00 ➝ $111.00Low
4/7/2022Piper SandlerDowngradeNeutral ➝ Underweight$92.00 ➝ $76.00Medium
3/25/2022Morgan StanleyLower Price TargetUnderweight$97.00 ➝ $95.00Low
3/22/2022Piper SandlerLower Price TargetNeutral$106.00 ➝ $92.00High
3/9/2022Piper SandlerLower Price TargetNeutral$122.00 ➝ $106.00Low
3/8/2022Morgan StanleyLower Price TargetUnderweight$106.00 ➝ $97.00High
2/9/2022Morgan StanleyBoost Price TargetUnderweight$101.00 ➝ $106.00Low
1/11/2022Morgan StanleyBoost Price TargetUnderweight$97.00 ➝ $101.00High
1/6/2022The Goldman Sachs GroupUpgradeNeutral ➝ Buy$116.00 ➝ $126.00High
1/4/2022CitigroupUpgradeNeutral ➝ BuyMedium
1/4/2022UBS GroupUpgradeNeutral ➝ Buy$120.00 ➝ $116.00High
12/8/2021Morgan StanleyLower Price TargetUnderweight ➝ Underweight$106.00 ➝ $97.00High
10/29/2021Morgan StanleyBoost Price TargetUnderweight$103.00 ➝ $106.00High
10/29/2021Keefe, Bruyette & WoodsUpgradeUnderperform ➝ Market Perform$86.00 ➝ $110.00High
10/26/2021JMP SecuritiesReiterated RatingHold ➝ HoldLow
7/14/2021Keefe, Bruyette & WoodsDowngradeMarket Perform ➝ Underperform$80.00High
3/25/2021The Goldman Sachs GroupReiterated RatingBuy ➝ Neutral$82.00 ➝ $73.00Low
3/19/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$82.00 ➝ $73.00High
1/29/2021Morgan StanleyLower Price TargetUnderweight$80.00 ➝ $77.00High
1/5/2021Wolfe ResearchDowngradePeer Perform ➝ Underperform$57.00 ➝ $63.00N/A
12/14/2020Morgan StanleyDowngradeEqual Weight ➝ Underweight$80.00High
10/12/2020Morgan StanleyBoost Price TargetEqual Weight$62.00 ➝ $65.00Low
10/2/2020UBS GroupDowngradeBuy ➝ Neutral$60.00Medium
7/22/2020Wolfe ResearchInitiated CoveragePeer Perform$60.00Medium
7/10/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$66.00 ➝ $57.00Medium
5/13/2020Morgan StanleyBoost Price TargetEqual Weight$58.00 ➝ $62.00High
5/13/2020UBS GroupBoost Price TargetBuy$55.00 ➝ $66.00High
4/9/2020Morgan StanleyBoost Price TargetEqual Weight$52.00 ➝ $58.00Low
3/25/2020UBS GroupLower Price TargetBuy$59.00 ➝ $55.00Medium
1/26/2020Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$52.00 ➝ $53.00Low
1/13/2020Buckingham ResearchBoost Price TargetBuy$51.00 ➝ $57.00High
11/27/2019Morgan StanleyInitiated CoverageEqual Weight$49.00N/A
11/20/2019Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$49.00Low
7/11/2019Buckingham ResearchLower Price TargetBuy$53.00 ➝ $51.00Low
5/23/2019JMP SecuritiesDowngradeOutperform ➝ Market Perform$46.65High
4/3/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$44.00 ➝ $52.00Low
1/9/2019Bank of AmericaUpgradeNeutral ➝ Buy$46.00 ➝ $47.00High
1/4/2019Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Outperform$47.00Medium
11/6/2018The Goldman Sachs GroupInitiated CoverageNeutral$46.00Medium
10/8/2018UBS GroupLower Price TargetBuy ➝ Buy$57.00 ➝ $55.00Medium
8/2/2018Sandler O'NeillReiterated RatingHold$52.00Low
7/27/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$55.00 ➝ $57.00High
6/26/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$50.00 ➝ $55.00Low
4/5/2018Buckingham ResearchInitiated CoverageBuy$54.00Medium
1/30/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$50.00 ➝ $52.00Low
1/11/2018Keefe, Bruyette & WoodsReiterated RatingBuy$52.00Medium
12/22/2017Keefe, Bruyette & WoodsReiterated RatingBuy$49.00Low
10/25/2017Bank of AmericaBoost Price TargetNeutral$40.00 ➝ $44.00N/A
10/25/2017UBS GroupBoost Price TargetBuy$44.00 ➝ $47.00N/A
10/3/2017Keefe, Bruyette & WoodsReiterated RatingBuyLow
9/12/2017JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$42.00High
8/27/2017Keefe, Bruyette & WoodsReiterated RatingBuy$40.00Low
7/27/2017Keefe, Bruyette & WoodsReiterated RatingBuy$40.00Low
7/26/2017UBS GroupReiterated RatingBuy$40.00 ➝ $42.00Medium
6/14/2017Keefe, Bruyette & WoodsReiterated RatingBuy$38.00Low
(Data available from 5/26/2017 forward)

News Sentiment Rating

0.11 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
11/27/2021
  • 7 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/27/2021
  • 6 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/26/2022
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2022
  • 3 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
3/27/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
4/26/2022
  • 1 very positive mentions
  • 15 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
5/26/2022

Current Sentiment

  • 1 very positive mentions
  • 15 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Houlihan Lokey logo
Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as financial sponsors on various transactions. It also provides financing solutions and capital-raising advisory services for publicly-held and multinational corporations, financial sponsors, and privately-held companies. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions. In addition, this segment offers dispute resolution consulting services. It serves corporations, financial sponsors, and government agencies. The company was founded in 1972 and is headquartered in Los Angeles, California.
Read More

Today's Range

Now: $83.79
Low: $83.31
High: $85.43

50 Day Range

MA: $86.46
Low: $81.68
High: $98.07

52 Week Range

Now: $83.79
Low: $73.73
High: $122.62

Volume

375,742 shs

Average Volume

448,373 shs

Market Capitalization

$5.64 billion

P/E Ratio

13.05

Dividend Yield

2.06%

Beta

0.65

Frequently Asked Questions

What sell-side analysts currently cover shares of Houlihan Lokey?

The following sell-side analysts have issued research reports on Houlihan Lokey in the last twelve months: Citigroup Inc., JMP Securities, Keefe, Bruyette & Woods, Morgan Stanley, Piper Sandler, StockNews.com, The Goldman Sachs Group, Inc., UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for HLI.

What is the current price target for Houlihan Lokey?

0 Wall Street analysts have set twelve-month price targets for Houlihan Lokey in the last year. Their average twelve-month price target is $98.40, suggesting a possible upside of 17.4%.
View the latest price targets for HLI.

What is the current consensus analyst rating for Houlihan Lokey?

Houlihan Lokey currently has 2 sell ratings, 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HLI, but not buy more shares or sell existing shares.
View the latest ratings for HLI.

How do I contact Houlihan Lokey's investor relations team?

Houlihan Lokey's physical mailing address is 10250 CONSTELLATION BLVD. 5TH FLOOR, LOS ANGELES CA, 90067. The financial services provider's listed phone number is (310) 788-5200 and its investor relations email address is [email protected] The official website for Houlihan Lokey is www.hl.com. Learn More about contacing Houlihan Lokey investor relations.